Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment
Completed · Phase 1
Conditions studied: Healthy, Renal Insufficiency
In brief
This study is being conducted in healthy subjects and in subjects with a mild or moderate decrease in GFR (subjects with renal impairment).
Key facts
- Study ID
- NCT04154670
- Run by
- Ensoma
- People needed
- 23
- Starts
- 2019-11-07
- Expected to finish
- 2020-03-24
- Last updated by the study team
- 2024-01-11
Who can join
Age: 18 and older, up to 79. Sex: any. Healthy volunteers: accepted.
Where it is running
- Orlando Clinical Research Center (OCRC) — Orlando, Florida, United States
- Alliance for Multispeciality Research (AMR) Formerly New Orleans Center for Clinical Research (NOCCR) — Knoxville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.